Accessibility settings

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/77927, first published .
Close-up of person scratching itchy arm with red rash

Efficacy of WuSheZhiYang Pills in Mild-to-Moderate Atopic Dermatitis: Protocol for a Double-Blind, Randomized, Placebo-Controlled Trial

Efficacy of WuSheZhiYang Pills in Mild-to-Moderate Atopic Dermatitis: Protocol for a Double-Blind, Randomized, Placebo-Controlled Trial

Journals

  1. Gao X, Duan Z, Xiao X, Shen F, Cai R, Zhang X, Xu Q, Zhang R, Wang R. Efficacy of Fuzhiqing ointment in mild-to-moderate atopic dermatitis: protocol for a multicenter, randomized, double-blind, placebo-controlled trial. Frontiers in Medicine 2026;12 View
  2. Gao X, Cai R, Lu J, Duan Z, Xu Q, Zhang X, Shen F, Zhang R, Li B, Wang R. Efficacy and safety of MuShengshu in the treatment of mild-to-moderate atopic dermatitis: protocol for a randomized, double-blind, placebo-controlled trial. Frontiers in Medicine 2026;13 View
  3. Ru N, Guo M, Xu H, Wu Y, Li Z, Wang R, Ouyang S, Cao Y, Sun W, Tan H, Wang H, Kurihara H, Liang L, Li Y, Yang Q, Huang Q, Ning N, Zheng X, Wu Y, He R. Oral Chinese Patent Medicine Alleviates Atopic Dermatitis by Regulating ALOX15-Derived Oxylipins Disorder. Phytomedicine 2026:158524 View
  4. Li D, Ma X, Xu C, Li X, Meng Y, Jiang W, Luo G, Liu Y, Shen F, Gao X, Wang R, Li B. Clinical Dose-Response of Inflammation Formula Number 1 Granules Versus Traditional Decoction in the Treatment of Patients With Mild to Moderate Atopic Dermatitis: Protocol for a Multicenter Randomized Controlled Trial. JMIR Research Protocols 2026;15:e96094 View